Skip to main navigation
Alumis Inc. Logo Skip to main content
  • About
    • Mission
    • Leadership
    • Board of Directors
  • Science
    • Approach
    • About TYK2
    • Anti-IGF-1R
    • Publications and Posters
  • Patients
    • Clinical Trials
    • Psoriasis
    • Lupus (SLE)
    • Thyroid Eye Disease (TED)
    • Patient Resources
    • Expanded Access Policy
  • Pipeline
    • Pipeline
    • Envudeucitinib for Psoriasis
    • Envudeucitinib for SLE
    • Lonigutamab
    • A-005
  • Careers
    • Job Opportunities
    • Values
    • Spotlights
    • Benefits
    • Life at Alumis
  • Investors
    • News
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Financials & Filings
    • IR Resources

Presentations

Alumis Corporate Presentation - August 2026 2 MB
Envudeucitinib ONWARD1 and ONWARD2 Phase 3 Data Presentation 2.7 MB
Alumis Envudeucitinib ONWARD Phase 3 Plaque Psoriasis Trial Results Event Presentation 901.2 KB
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR
  • Overview
  • News
  • Events & Presentations
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • More
    • Home
    • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historic Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Corporate Governance
        • Documents & Charters
        • Management Team
        • Board of Directors
        • Committee Composition
      • Financials & Filings
        • SEC Filings
      • IR Resources
        • Investor FAQs
        • Email Alerts
        • Contact IR
    • About
      • Mission
      • Leadership
      • Board of Directors
    • Our Approach
      • Why It Matters
    • Pipeline
      • About TYK2
      • ESK-001
      • A-005
      • Publications
    • Careers
      • Job Opportunities
      • Values
      • Life at Alumis
    • Contact
    Alumis Inc. Logo

    Alumis Inc.
    280 East Grand Avenue
    South San Francisco
    CA 94080
    (650) 231-6625

    Contact

    Business Development
    bd@alumis.com

    General Inquiries
    info@alumis.com

    Careers
    careers@alumis.com

    Medical Affairs
    Contact our Medical Affairs Team

    • LinkedIn
    • Twitter
    • Privacy Policy
    © 2026 Alumis Inc. All rights reserved.
    Website Design: Hane Chow, Inc.